Global Medical REIT (GMRE) Expected to Announce Earnings on Tuesday

Key Points

• Global Medical REIT (GMRE) is set to announce its Q2 2025 earnings on August 5th, with analysts predicting earnings of $0.23 per share and revenues of $35.57 million.
• The company recently cut its dividend to $0.15 per share, resulting in an annual yield of 8.66%, while the dividend payout ratio stands at a staggering 2,000.00%.
• CEO Mark Okey Decker, Jr. increased his ownership in GMRE by purchasing 57,332 shares at $6.50 each, bringing his total to 160,000 shares valued at approximately $1.04 million.

Global Medical REIT (NYSE:GMRE - Get Free Report) will likely be issuing its Q2 2025 quarterly earnings data after the market closes on Tuesday, August 5th. Analysts expect the company to announce earnings of $0.23 per share and revenue of $35.57 million for the quarter. Global Medical REIT has set its FY 2025 guidance at 0.890-0.930 EPS.

Global Medical REIT (NYSE:GMRE - Get Free Report) last announced its quarterly earnings results on Wednesday, May 7th. The company reported $0.22 earnings per share for the quarter, meeting the consensus estimate of $0.22. The company had revenue of $34.60 million during the quarter, compared to the consensus estimate of $35.49 million. Global Medical REIT had a net margin of 5.87% and a return on equity of 1.68%. On average, analysts expect Global Medical REIT to post $1 EPS for the current fiscal year and $1 EPS for the next fiscal year.

Global Medical REIT Stock Up 1.0%

Shares of GMRE traded up $0.07 on Friday, hitting $6.75. 344,420 shares of the stock traded hands, compared to its average volume of 606,749. The company has a market capitalization of $451.11 million, a PE ratio of 225.38, a P/E/G ratio of 1.15 and a beta of 1.16. The company has a debt-to-equity ratio of 1.44, a quick ratio of 0.26 and a current ratio of 0.26. The business has a 50 day simple moving average of $6.70 and a 200 day simple moving average of $7.50. Global Medical REIT has a one year low of $6.05 and a one year high of $10.46.

Global Medical REIT Cuts Dividend

The business also recently announced a quarterly dividend, which was paid on Wednesday, July 9th. Shareholders of record on Friday, June 20th were given a $0.15 dividend. This represents a $0.60 dividend on an annualized basis and a yield of 8.9%. Global Medical REIT's dividend payout ratio (DPR) is presently 2,000.00%.

Insider Buying and Selling at Global Medical REIT

In other Global Medical REIT news, CEO Mark Okey Decker, Jr. purchased 102,668 shares of the company's stock in a transaction dated Tuesday, June 24th. The shares were acquired at an average price of $6.52 per share, for a total transaction of $669,395.36. Following the purchase, the chief executive officer directly owned 102,668 shares of the company's stock, valued at $669,395.36. The trade was a ∞ increase in their position. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. 8.50% of the stock is owned by corporate insiders.

Institutional Inflows and Outflows

Institutional investors and hedge funds have recently modified their holdings of the business. AQR Capital Management LLC lifted its stake in shares of Global Medical REIT by 9.5% during the 1st quarter. AQR Capital Management LLC now owns 58,538 shares of the company's stock valued at $512,000 after buying an additional 5,062 shares in the last quarter. Envestnet Asset Management Inc. lifted its stake in shares of Global Medical REIT by 39.5% during the 2nd quarter. Envestnet Asset Management Inc. now owns 26,617 shares of the company's stock valued at $184,000 after buying an additional 7,536 shares in the last quarter. Strs Ohio purchased a new position in shares of Global Medical REIT during the 1st quarter valued at $95,000. Jones Financial Companies Lllp lifted its stake in shares of Global Medical REIT by 23,920.0% during the 1st quarter. Jones Financial Companies Lllp now owns 24,020 shares of the company's stock valued at $210,000 after buying an additional 23,920 shares in the last quarter. Finally, Goldman Sachs Group Inc. lifted its stake in shares of Global Medical REIT by 13.2% during the 1st quarter. Goldman Sachs Group Inc. now owns 388,605 shares of the company's stock valued at $3,400,000 after buying an additional 45,243 shares in the last quarter. Hedge funds and other institutional investors own 57.52% of the company's stock.

Analyst Ratings Changes

A number of research firms have commented on GMRE. Wall Street Zen downgraded shares of Global Medical REIT from a "hold" rating to a "sell" rating in a research report on Thursday, May 22nd. Robert W. Baird cut their target price on shares of Global Medical REIT from $10.00 to $9.00 and set a "neutral" rating for the company in a research report on Thursday, May 8th. Finally, B. Riley began coverage on shares of Global Medical REIT in a research report on Thursday, April 3rd. They issued a "neutral" rating and a $9.00 target price for the company. One investment analyst has rated the stock with a sell rating, two have assigned a hold rating and two have given a buy rating to the company's stock. According to data from MarketBeat, the stock currently has a consensus rating of "Hold" and a consensus price target of $10.44.

About Global Medical REIT

Global Medical REIT Inc (GMRE) is a net-lease medical office real estate investment trust (REIT) that owns and acquires healthcare facilities and leases those facilities to physician groups and regional and national healthcare systems.